Missing: Ogilvy Health's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Ogilvy Health's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Ogilvy Health News
Feb 24, 2023
Beth Snyder Bulik Senior Editor AstraZeneca is offering a look behind the pharma’s front doors with a new US leadership profile series and an inside science explainer podcast. The online executive series called “Personified” debuted last year, but AZ recently began promoting it on social media. Eight US leaders’ stories are now up on the website, including US biopharma business unit chief Joris Silon and corporate and government affairs head Christie Bloomquist. The profiles chronicle the executives’ early lives and influences leading them to careers at AstraZeneca. Brendan McEvoy “The goal is to pull back the curtain if you will, into AstraZeneca and highlight the unique motivations and personalities of our US leadership teams,” said Brendan McEvoy, US head of external communications. “…Sometimes outside the walls of AstraZeneca, we might not be perceived as people first – with ambitions and motivations and experiences, and so we wanted to open up that door.” McEvoy is also the host of the podcast series “That’s Understandable.” As the title implies, the intent of the audio chats is to break down and explain complex science ideas so that listeners walk away understanding the topic. As he explains in a short introduction, the podcast aims “to help break down a variety of issues at intersection of healthcare, business, culture and our planet. Ideally leaving each episode with a greater understanding of how we got to that point and what AstraZeneca is doing to help create a positive impact.” The first 25-minute episode, called “Moving Mountains,” is a conversation with Silon about his personal life — he’s working to become more and more vegetarian in his food choices and is learning to garden — but also the aspirations of the AstraZeneca pharma business and broader concerns around sustainability and climate change. With just one episode aired — and the March podcast on health equity being readied — McEvoy said employees and others are pitching ideas and topics for future chats. The goal for each episode is one AstraZeneca leader and an external guest for additional insight. “We’re definitely looking at different ways in which we can reach the various stakeholders or audience that we interact with,” McEvoy said, ticking off a laundry list of people including healthcare workers, pharma employees, caregivers, patients, employees, patient advocacy groups, professional societies and government agency workers who might be interested in the profile series and podcasts. AUTHOR Associate Editor Pfizer is ending its work with research contractor Care Access on an 18,000-patient Lyme disease vaccine trial, according to an internal email reviewed by Endpoints News, widening the breach that has emerged between the drug giant and the richly-valued research startup in recent days. Last week, Pfizer said it was removing thousands of patients recruited by Care Access from the Phase III work, citing issues with how Care Access had conducted its part of the trial. At the time, it was unclear whether any collaboration between the companies on the Lyme research would continue and if Care Access would recruit new patients. Premium subscription required Beth Snyder Bulik Senior Editor Bristol Myers Squibb’s social media savvy nabbed it the top spot in Ogilvy Health’s newest report ranking of 10 leading Big Pharmas. It was followed by Boehringer Ingelheim, Roche, GSK and AstraZeneca to round out the top five receiving the best overall scores. BMS led in the specific areas of content strategy and social influence across the six social measures Ogilvy scores the pharmas on. Ogilvy evaluated the pharmas in six social measures, including corporate identity, experience and design, paid social, and social community, along with strategy and influence. Its research audited pharma engagement on social channels Facebook, Instagram, Twitter, YouTube and LinkedIn. Keep reading Endpoints with a free subscription Unlock this story instantly and join 161,300+ biopharma pros reading Endpoints daily — and it's free. SIGN UP John Carroll Editor & Founder The roller-coaster ride of highs and lows at Cambridge, MA-based Fulcrum Therapeutics just took a sickening plunge. Weeks after using some upbeat results to set the stage for a $125 million raise — no easy feat in this market — the Fulcrum team got hit with a full clinical hold on one of their top drugs. And the news ripped up a chunk of market value that sent shares $FULC tumbling more than 50% Friday morning. Keep reading Endpoints with a free subscription Unlock this story instantly and join 161,300+ biopharma pros reading Endpoints daily — and it's free. SIGN UP LOG IN
Ogilvy Health Frequently Asked Questions (FAQ)
Where is Ogilvy Health's headquarters?
Ogilvy Health's headquarters is located at No. 6, Shangdi Chuangye Road, Haidian.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.